Position in DHR
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$647,632
-$418,488 QoQ
Shares Held
3,400
-39.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,239
of 2,098 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NorthCrest Asset Manangement, LLC holds $36,393,398 across 13 Diagnostics & Research names. DHR ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
40,344 | $20,226,867 | |
| 2 | LH |
Labcorp Holdings Inc.
|
31,591 | $8,845,480 | |
| 3 | ILMN |
Illumina, Inc.
|
8,137 | $1,430,728 | |
| 4 | NTRA |
Natera, Inc.
|
5,160 | $1,400,682 | |
| 5 | A |
Agilent Technologies, Inc.
|
7,093 | $942,163 | |
| 6 | DHR |
Danaher Corp /De/
This page
|
3,400 | $647,632 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
3,116 | $602,073 | |
| 8 | RVTY |
Revvity, Inc.
|
5,103 | $567,759 |
All Filings in DHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $647,632 | 3,400 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,066,120 | 5,623 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,231,589 | 5,380 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $767,662 | 3,872 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $390,734 | 1,978 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $262,195 | 1,279 | Shares | Sole | 2025-04-16 | |
| 2022-03-31 | $210,904 | 719 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $230,964 | 702 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||